| Literature DB >> 29921243 |
Coral Hanevold1, Susan Halbach2, Jin Mou3, Karyn Yonekawa2.
Abstract
BACKGROUND: We have noted a large number of referrals for abnormal kidney imaging and laboratory tests and postulated that such referrals have increased significantly over time. Understanding changes in referral patterns is helpful in tailoring education and communication between specialists and primary providers.Entities:
Keywords: Ambulatory referrals; Nephrology; Pediatrics
Mesh:
Year: 2018 PMID: 29921243 PMCID: PMC6010179 DOI: 10.1186/s12887-018-1164-1
Source DB: PubMed Journal: BMC Pediatr ISSN: 1471-2431 Impact factor: 2.125
Indications for Referral
| HBP | Elevated blood pressures/hypertension |
|---|---|
| HEM/PRO | Hematuria and/or proteinuria |
| UTI/VUR | Urinary tract infection and/or vesicoureteral reflux |
| ABN IMAGING | Includes solitary kidney, hydronephrosis, dilation of collecting systems, horseshoe kidney, duplicated collecting systems, isolated simple cysts, multicystic kidney, and other minor abnormalities such as abnormal size or appearance of one or both kidneys |
| ↓GFR | Decreased glomerular filtration rate, acute or chronic, includes hemolytic uremic syndrome |
| STONES/NC | Stones/nephrocalcinosis and hypercalciuria |
| MICROALB | Microalbuminuria |
| GLOM/VAS | Glomerular disease or vasculitis, includes nephrotic syndrome, Henoch Schonlein purpura, hereditary nephritis, acute glomerulonephritis or vasculitis of any type |
| VOIDING ISSUES | Includes enuresis, urinary frequency or urgency, dysuria, polyuria, daytime incontinence |
| ABN LABS | Abnormal laboratory studies (urine or blood) excluding hypercalciuria, microalbuminuria |
| OTHER | Such as tuberous sclerosis, polycystic kidney disease, Bardel Biedel syndrome, Beckwith Wiedeman, prenatal counseling, edema, flank pain, family history of kidney disease |
Referral Indications for Early and Late Cohorts*
| Indication for Referral | Early Cohort (2002–2004) | Late Cohorts (2011–2013) | Odds Ratio‡ [95% CI] | |
|---|---|---|---|---|
| HBP | 107 (20.9%) | 120 (23.6%) | 1.024, 0.311 | 1.165 [0.867, 1.565 |
| HEM/PRO | 108 (21.1%) | 105 (20.6%) | 0.040, 0.842 | 0.970 [0.717, 1.312] |
| UTIs/VUR* | 87 (17.0%) | 41 (8.1%) | 18.698, 0.000 | 0.472 [0.288, 0.633] |
| ABN IMAGING | 79 (15.5%) | 96 (19.1%) | 2.311, 0.128 | 1.287 [0.929, 1.784] |
| VOIDING ISSUES* | 34 (6.7%) | 10 (2.0%) | 13.583, 0.000 | 0.281 [0.137, 0.575] |
| ↓GFR | 21 (4.1%) | 18 (3.5%) | 0.228, 0.633 | 0.855 [0.450, 1.625] |
| STONES/NC | 17 (3.3%) | 23 (4.5%) | 0.961, 0.327 | 1.375 [0.726, 2.606] |
| GLOM/VAS | 20 (3.9%) | 30 (5.9%) | 2.145, 0.143 | 1.538 [0.861, 2.745] |
| ABN LABS† | 16 (3.1%) | 31 (6.1%) | 5.080, 0.024 | 2.006 [1.083, 3.716] |
| MICROALB† | 5 (1.0%) | 14 (2.8%) | 4.380, 0.036 | 2.862 [1.023, 8.006] |
| OTHER | 17 (3.3%) | 21 (4.1%) | 0.454, 0.501 | 1.250 [0.652, 2.399] |
Overall frequencies within categories differed (p < 0.001 comparing cohorts)
HBP elevated blood pressure or hypertension, HEM/PRO hematuria and/or proteinuria, UTI/VUR urinary tract infection/vesicoureteral reflux, ABN abnormal, ↓GFR decreased glomerular filtration rate, NC nephrocalcinosis; GLOM/VAS, glomerular disease, vasculitis, LABS laboratory studies, MICROALB microalbuminuria; OTHER (as defined in Table 1)
*p < .001, †p < .05, ‡Early cohort as reference
Referrals for Imaging
| Early cohort (2002–2004) | Late cohort (2011–2013) | ||
|---|---|---|---|
| Referral Indication | n (% within cohort, % within category) | n (% within cohort, % within category) | χ [ |
| Total | 79 (15.5%) | 96 (18.9%) | 2.311, 0.128, |
| ABN, US, OR CT IMAGING | 20 (3.9, 25.0%) | 31 (6.1, 32.0%) | 2.543, 0.111, |
| SK OR MCKD* | 19 (3.7, 24%) | 35 (6.9, 37.0%) | 5.072, 0.024, |
| HYDRO/DILATION UT | 40 (7.8, 51.0%) | 30 (5.9, 31.0%) | 1.492, 0.222, |
ABN abnormal, US ultrasound, CT computed tomography, SK solitary kidney, MCDK multi-cystic dysplastic kidney, HYDRO/DILATION UT, hydronephrosis/dilation of urinary tract
*p < 0.05